TLX – telix pharmaceuticals limited - american depositary shares (US:NASDAQ)
Stock Stats
News
Telix to Add FAP-Targeting Candidates to Theranostic Pipeline
Telix to Add FAP-Targeting Candidates to Theranostic Pipeline
Telix to Add FAP-Targeting Candidates to Theranostic Pipeline
Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ: TLX) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $21.00 price target on the stock.
Telix ADSs Commence Trading on Nasdaq
Form 6-K Telix Pharmaceuticals For: Nov 19
Form 6-K Telix Pharmaceuticals For: Nov 12
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.